The page is the record's research on the issuer — no analyst, no rating, no view. # Theriva Biologics, Inc. (NYSE: TOVX) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing Theriva Biologics, Inc. is listed on the NYSE under the ticker TOVX, with ISIN US87164U5083 and LEI 529900RVC1I52VWB3G55. Its security type is Corporate and its sector is 2834 Pharmaceutical Preparations. Its jurisdiction is United States — Nevada, and its segment is not on the record. Its listing status is listed, not halted. ## The disclosure read The record holds 44 filings on 34 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 8 days, against an exchange median of 6.0 days and a sector median of 6.0 days. The latest filing is dated 2026-11-02, a corporate news filing, 6 days before the record date. The exchange median latency is 4.0 days and the sector median latency is 4.0 days. The exchange median count of filings is 64.0 and the sector median is 63.0. ## Auditor The auditor of record is BDO USA, P.C, located in Raleigh, North Carolina. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage The issuer's own investor-relations page names 2 research houses: A.G.P. / Alliance Global Partners and Maxim Group. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. ## Sources 10 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0000894158.json (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://mcp.us-cm-kg.ai/events/NYSE/TOVX (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/894158/000110465926026767/tmb-20251231x10k.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://therivabio.com/investors/stock-information/ (coverage) - https://mcp.us-cm-kg.ai/record/NYSE/TOVX (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NYSE/TOVX · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp